Trial Profile
Protocol: HL/IDP/PTS/001 Tumour Profiling In An Open-Labelled, 2-Arm Study Investigating The Tolerability And Efficacy Of Taxotere In Patients With High Risk Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2019
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Goserelin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms GENTAX
- 15 Mar 2011 New trial record
- 19 Feb 2011 Interim results presented at the 2011 Genitourinary Cancers Symposium.